Grant: Idea to Innovation
University of Toronto
$124,750.00
Development of an automated blood cell counting system for clinical assessment of feto-maternal hemorrhage
EF 2014-15
Résumé
The KB (Kleihauer-Betke) test is a blood test performed on approximately 15-20% of pregnant women to measure the number of fetal red blood cells entering from a fetus into a mother's bloodstream (i.e., fetal-maternal hemorrhage). Fetal-maternal hemorrhage can result from Rhesus hemolytic (Rh) diseases or loss of integrity of the normal physiological barrier between the fetal and maternal circulation. The state-of-the-art practice in hospitals for KB test relies on manual counting by certified technologists. A lab technologist prepares a blood smear from the mother's blood. Sample preparation with an acid results in a KB slide where fetal red blood cells appear dark red and maternal cells appear light pinkish. The lab technologist, looking through the eyepieces of a microscope, manually counts the fetal and maternal red blood cells (RBCs). To have reliable results a minimum of 2,000 cells are counted and the percentage of fetal to maternal cells is calculated. Manual counting of 2,000 cells takes ~15-20 minutes. Human errors are always a clinical concern because of the nature of the manually performed task. This project aims to develop a low-cost instrument prototype for automated fetal and maternal RBC count in clinical KB test. The system prototype will include custom-developed hardware for positioning and imaging KB slides, and a software package for controlling the hardware and processing RBC images to count and distinguish fetal and maternal RBCs. The system will position KB slides to count a high number of cells (>20,000 cells vs. 2,000 cells) and will enhance the accuracy of traditional KB tests. We will also prove that the low-cost instrument will offer significant savings in time and efforts (2 minute automated operation vs. 20 minutes manual counting). Within this project, we will evaluate the performance of the system prototype and compare KB test results with those from certified hospital technologists and benchmark results from flow cytometry. The technology has the potential to standardize how RBCs are counted in clinical KB test.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
461359-2014
Name nom
Sun, Yu
Department département
Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
124750
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
515
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Instrumentation technology
Area of application fr
Technologie de l'instrumentation
Research subject code
2109
Research subject group en
Mechanical engineering
Research subject group fr
Génie mécanique
Research subject en
Mechanical systems and instrumentation
Research subject fr
Instrumentation et systèmes mécaniques
Partie
1
Nb partie
1
Application title
Development of an automated blood cell counting system for clinical assessment of feto-maternal hemorrhage
Keyword
NSERC
Application summary
The KB (Kleihauer-Betke) test is a blood test performed on approximately 15-20% of pregnant women to measure the number of fetal red blood cells entering from a fetus into a mother's bloodstream (i.e., fetal-maternal hemorrhage). Fetal-maternal hemorrhage can result from Rhesus hemolytic (Rh) diseases or loss of integrity of the normal physiological barrier between the fetal and maternal circulation. The state-of-the-art practice in hospitals for KB test relies on manual counting by certified technologists. A lab technologist prepares a blood smear from the mother's blood. Sample preparation with an acid results in a KB slide where fetal red blood cells appear dark red and maternal cells appear light pinkish. The lab technologist, looking through the eyepieces of a microscope, manually counts the fetal and maternal red blood cells (RBCs). To have reliable results a minimum of 2,000 cells are counted and the percentage of fetal to maternal cells is calculated. Manual counting of 2,000 cells takes ~15-20 minutes. Human errors are always a clinical concern because of the nature of the manually performed task. This project aims to develop a low-cost instrument prototype for automated fetal and maternal RBC count in clinical KB test. The system prototype will include custom-developed hardware for positioning and imaging KB slides, and a software package for controlling the hardware and processing RBC images to count and distinguish fetal and maternal RBCs. The system will position KB slides to count a high number of cells (>20,000 cells vs. 2,000 cells) and will enhance the accuracy of traditional KB tests. We will also prove that the low-cost instrument will offer significant savings in time and efforts (2 minute automated operation vs. 20 minutes manual counting). Within this project, we will evaluate the performance of the system prototype and compare KB test results with those from certified hospital technologists and benchmark results from flow cytometry. The technology has the potential to standardize how RBCs are counted in clinical KB test.